Induction of the human cathelicidin LL-37 as a novel treatment against bacterial infections

Journal of Leukocyte Biology

Volumn 92, Issue 4, 2012, Pages 735-742

  van der Does, Anne M ^a   Bergman, Peter ^b   Agerberth, Birgitta ^a   Lindbom, Lennart ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antimicrobial peptides; Butyrate phenylbutyrate; Innate immunity; Vitamin D3

Indexed keywords

BUTYRIC ACID; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; COLECALCIFEROL;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BRONCHUS MUCOSA; COLON MUCOSA; EPITHELIUM CELL; FEASIBILITY STUDY; HUMAN; INNATE IMMUNITY; LEUKOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SKIN EPITHELIUM;

ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL INFECTIONS; BRONCHI; BUTYRATES; CHOLECALCIFEROL; COLON; HUMANS; IMMUNITY, INNATE; NEUTROPHILS; SKIN;

BACTERIA (MICROORGANISMS);

EID: 84868093334     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.0412178     Document Type: Article

References (104)

1. Chen, L. F., Chopra, T., Kaye, K. S. (2009) Pathogens resistant to antibacterial agents. Infect. Dis. Clin. North Am. 23, 817-845.
2. Guani-Guerra, E., Santos-Mendoza, T., Lugo-Reyes, S. O., Teran, L. M. (2010) Antimicrobial peptides: general overview and clinical implications in human health and disease. Clin. Immunol. 135, 1-11.
3. Radek, K., Gallo, R. (2007) Antimicrobial peptides: natural effectors of the innate immune system. Semin. Immunopathol. 29, 27-43.
4. Lai, Y., Gallo, R. L. (2009) AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol. 30, 131-141.
5. Zasloff, M. (2002) Antimicrobial peptides of multicellular organisms. Nature 415, 389-395.
6. Fjell, C. D., Hiss, J. A., Hancock, R. E., Schneider, G. (2012) Designing antimicrobial peptides: form follows function. Nat. Rev. Drug Discov. 11, 37-51.
7. Epand, R. M., Vogel, H. J. (1999) Diversity of antimicrobial peptides and their mechanisms of action. Biochim. Biophys. Acta 1462, 11-28.
8. Hale, J. D., Hancock, R. E. (2007) Alternative mechanisms of action of cationic antimicrobial peptides on bacteria. Expert Rev. Anti. Infect. Ther. 5, 951-959.
9. Easton, D. M., Nijnik, A., Mayer, M. L., Hancock, R. E. (2009) Potential of immunomodulatory host defense peptides as novel anti-infectives. Trends Biotechnol. 27, 582-590.
10. Sorensen, O. E., Follin, P., Johnsen, A. H., Calafat, J., Tjabringa, G. S., Hiemstra, P. S., Borregaard, N. (2001) Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 97, 3951-3959.
11. Yamasaki, K., Schauber, J., Coda, A., Lin, H., Dorschner, R. A., Schechter, N. M., Bonnart, C., Descargues, P., Hovnanian, A., Gallo, R. L. (2006) Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin. FASEB J. 20, 2068-2080.
12. Bucki, R., Leszczynska, K., Namiot, A., Sokolowski, W. (2010) Cathelicidin LL-37: a multitask antimicrobial peptide. Arch. Immunol. Ther. Exp. (Warsz) 58, 15-25.
13. Nijnik, A., Hancock, R. E. (2009) The roles of cathelicidin LL-37 in immune defences and novel clinical applications. Curr. Opin. Hematol. 16, 41-47.
14. Kai-Larsen, Y., Agerberth, B. (2008) The role of the multifunctional peptide LL-37 in host defense. Front. Biosci. 13, 3760-3767.
15. Schauber, J., Dorschner, R. A., Yamasaki, K., Brouha, B., Gallo, R. L. (2006) Control of the innate epithelial antimicrobial response is celltype specific and dependent on relevant microenvironmental stimuli. Immunology 118, 509-519.
16. Nell, M. J., Tjabringa, G. S., Vonk, M. J., Hiemstra, P. S., Grote, J. J. (2004) Bacterial products increase expression of the human cathelicidin hCAP-18/LL-37 in cultured human sinus epithelial cells. FEMS Immunol. Med. Microbiol. 42, 225-231.
17. Wang, T. T., Nestel, F. P., Bourdeau, V., Nagai, Y., Wang, Q., Liao, J., Tavera-Mendoza, L., Lin, R., Hanrahan, J. W., Mader, S., White, J. H. (2004) Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J. Immunol. 173, 2909-2912.
18. Schauber, J., Iffland, K., Frisch, S., Kudlich, T., Schmausser, B., Eck, M., Menzel, T., Gostner, A., Luhrs, H., Scheppach, W. (2004) Histonedeacetylase inhibitors induce the cathelicidin LL-37 in gastrointestinal cells. Mol. Immunol. 41, 847-854.
19. Termen, S., Tollin, M., Rodriguez, E., Sveinsdottir, S. H., Johannesson, B., Cederlund, A., Sjovall, J., Agerberth, B., Gudmundsson, G. H. (2008) PU. 1 and bacterial metabolites regulate the human gene CAMP encoding antimicrobial peptide LL-37 in colon epithelial cells. Mol. Immunol. 45, 3947-3955.
20. Mendez-Samperio, P., Miranda, E., Trejo, A. (2008) Expression and secretion of cathelicidin LL-37 in human epithelial cells after infection by Mycobacterium bovis bacillus Calmette-Guerin. Clin. Vaccine Immunol. 15, 1450-1455.
21. Park, K., Elias, P. M., Oda, Y., Mackenzie, D., Mauro, T., Holleran, W. M., Uchida, Y. (2011) Regulation of cathelicidin antimicrobial peptide expression by an endoplasmic reticulum (ER) stress signaling, vitamin D receptor-independent pathway. J. Biol. Chem. 286, 34121-34130.
22. Islam, D., Bandholtz, L., Nilsson, J., Wigzell, H., Christensson, B., Agerberth, B., Gudmundsson, G. (2001) Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat. Med. 7, 180-185.
23. Bergman, P., Johansson, L., Asp, V., Plant, L., Gudmundsson, G. H., Jonsson, A. B., Agerberth, B. (2005) Neisseria gonorrhoeae downregulates expression of the human antimicrobial peptide LL-37. Cell. Microbiol. 7, 1009-1017.
24. Chakraborty, K., Ghosh, S., Koley, H., Mukhopadhyay, A. K., Ramamurthy, T., Saha, D. R., Mukhopadhyay, D., Roychowdhury, S., Hamabata, T., Takeda, Y., Das, S. (2008) Bacterial exotoxins downregulate catheli-cidin (hCAP-18/LL-37) and human β-defensin 1 (HBD-1) expression in the intestinal epithelial cells. Cell. Microbiol. 10, 2520-2537.
25. Otte, J. M., Zdebik, A. E., Brand, S., Chromik, A. M., Strauss, S., Schmitz, F., Steinstraesser, L., Schmidt, W. E. (2009) Effects of the cathelicidin LL-37 on intestinal epithelial barrier integrity. Regul. Pept. 156, 104-117.
26. Otte, J. M., Werner, I., Brand, S., Chromik, A. M., Schmitz, F., Kleine, M., Schmidt, W. E. (2008) Human β defensin 2 promotes intestinal wound healing in vitro. J. Cell. Biochem. 104, 2286-2297.
27. Shaykhiev, R., Beisswenger, C., Kandler, K., Senske, J., Puchner, A., Damm, T., Behr, J., Bals, R. (2005) Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure. Am. J. Physiol. Lung Cell. Mol. Physiol. 289, L842-L848.
28. Byfield, F. J., Kowalski, M., Cruz, K., Leszczynska, K., Namiot, A., Savage, P. B., Bucki, R., Janmey, P. A. (2011) Cathelicidin LL-37 increases lung epithelial cell stiffness, decreases transepithelial permeability, and prevents epithelial invasion by Pseudomonas aeruginosa. J. Immunol. 187, 6402-6409.
29. Barlow, P. G., Beaumont, P. E., Cosseau, C., Mackellar, A., Wilkinson, T. S., Hancock, R. E., Haslett, C., Govan, J. R., Simpson, A. J., Davidson, D. J. (2010) The human cathelicidin LL-37 preferentially promotes apoptosis of infected airway epithelium. Am. J. Respir. Cell Mol. Biol. 43, 692-702.
30. Grassme, H., Kirschnek, S., Riethmueller, J., Riehle, A., von Kurthy, G., Lang, F., Weller, M., Gulbins, E. (2000) CD95/CD95 ligand interactions on epithelial cells in host defense to Pseudomonas aeruginosa. Science 290, 527-530.
31. Tjabringa, G. S., Aarbiou, J., Ninaber, D. K., Drijfhout, J. W., Sorensen, O. E., Borregaard, N., Rabe, K. F., Hiemstra, P. S. (2003) The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor. J. Immunol. 171, 6690-6696.
32. Scott, M. G., Davidson, D. J., Gold, M. R., Bowdish, D., Hancock, R. E. (2002) The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J. Immunol. 169, 3883-3891.
33. Niyonsaba, F., Ushio, H., Nakano, N., Ng, W., Sayama, K., Hashimoto, K., Nagaoka, I., Okumura, K., Ogawa, H. (2007) Antimicrobial peptides human β-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines. J. Invest. Dermatol. 127, 594-604.
34. Chamorro, C. I., Weber, G., Gronberg, A., Pivarcsi, A., Stahle, M. (2009) The human antimicrobial peptide LL-37 suppresses apoptosis in keratinocytes. J. Invest. Dermatol. 129, 937-944.
35. Heilborn, J. D., Nilsson, M. F., Kratz, G., Weber, G., Sorensen, O., Borregaard, N., Stahle-Backdahl, M. (2003) The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J. Invest. Dermatol. 120, 379-389.
36. Nagaoka, I., Tamura, H., Hirata, M. (2006) An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7. J. Immunol. 176, 3044-3052.
37. Bjorstad, A., Askarieh, G., Brown, K. L., Christenson, K., Forsman, H., Onnheim, K., Li, H. N., Teneberg, S., Maier, O., Hoekstra, D., Dahlgren, C., Davidson, D. J., Bylund, J. (2009) The host defense peptide LL-37 selectively permeabilizes apoptotic leukocytes. Antimicrob. Agents Chemother. 53, 1027-1038.
38. Li, H. N., Barlow, P. G., Bylund, J., Mackellar, A., Bjorstad, A., Conlon, J., Hiemstra, P. S., Haslett, C., Gray, M., Simpson, A. J., Rossi, A. G., Davidson, D. J. (2009) Secondary necrosis of apoptotic neutrophils induced by the human cathelicidin LL-37 is not proinflammatory to phagocytosing macrophages. J. Leukoc. Biol. 86, 891-902.
39. Zhang, Z., Cherryholmes, G., Shively, J. E. (2008) Neutrophil secondary necrosis is induced by LL-37 derived from cathelicidin. J. Leukoc. Biol. 84, 780-788.
40. Alalwani, S. M., Sierigk, J., Herr, C., Pinkenburg, O., Gallo, R., Vogelmeier, C., Bals, R. (2010) The antimicrobial peptide LL-37 modulates the inflammatory and host defense response of human neutrophils. Eur. J. Immunol. 40, 1118-1126.
41. Mookherjee, N., Brown, K. L., Bowdish, D. M., Doria, S., Falsafi, R., Hokamp, K., Roche, F. M., Mu, R., Doho, G. H., Pistolic, J., Powers, J. P., Bryan, J., Brinkman, F. S., Hancock, R. E. (2006) Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. J. Immunol. 176, 2455-2464.
42. Mookherjee, N., Lippert, D. N., Hamill, P., Falsafi, R., Nijnik, A., Kindrachuk, J., Pistolic, J., Gardy, J., Miri, P., Naseer, M., Foster, L. J., Hancock, R. E. (2009) Intracellular receptor for human host defense peptide LL-37 in monocytes. J. Immunol. 183, 2688-2696.
43. Van der Does, A. M., Beekhuizen, H., Ravensbergen, B., Vos, T., Ottenhoff, T. H., van Dissel, J. T., Drijfhout, J. W., Hiemstra, P. S., Nibbering, P. H. (2010) LL-37 directs macrophage differentiation toward macrophages with a proinflammatory signature. J. Immunol. 185, 1442-1449.
44. Davidson, D. J., Currie, A. J., Reid, G. S., Bowdish, D. M., MacDonald, K. L., Ma, R. C., Hancock, R. E., Speert, D. P. (2004) The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J. Immunol. 172, 1146-1156.
45. Kandler, K., Shaykhiev, R., Kleemann, P., Klescz, F., Lohoff, M., Vogelmeier, C., Bals, R. (2006) The anti-microbial peptide LL-37 inhibits the activation of dendritic cells by TLR ligands. Int. Immunol. 18, 1729-1736.
46. Howell, M. D., Jones, J. F., Kisich, K. O., Streib, J. E., Gallo, R. L., Leung, D. Y. (2004) Selective killing of vaccinia virus by LL-37: implications for eczema vaccinatum. J. Immunol. 172, 1763-1767.
47. Nizet, V., Ohtake, T., Lauth, X., Trowbridge, J., Rudisill, J., Dorschner, R. A., Pestonjamasp, V., Piraino, J., Huttner, K., Gallo, R. L. (2001) Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414, 454-457.
48. Huang, L. C., Reins, R. Y., Gallo, R. L., McDermott, A. M. (2007) Cathelicidin-deficient (Cnlp-/-) mice show increased susceptibility to Pseudomonas aeruginosa keratitis. Invest. Ophthalmol. Vis. Sci. 48, 4498-4508.
49. Chromek, M., Slamova, Z., Bergman, P., Kovacs, L., Podracka, L., Ehren, I., Hokfelt, T., Gudmundsson, G. H., Gallo, R. L., Agerberth, B., Brauner, A. (2006) The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat. Med. 12, 636-641.
50. Iimura, M., Gallo, R. L., Hase, K., Miyamoto, Y., Eckmann, L., Kagnoff, M. F. (2005) Cathelicidin mediates innate intestinal defense against colonization with epithelial adherent bacterial pathogens. J. Immunol. 174, 4901-4907.
51. Bals, R., Weiner, D. J., Moscioni, A. D., Meegalla, R. L., Wilson, J. M. (1999) Augmentation of innate host defense by expression of a cathelicidin antimicrobial peptide. Infect. Immun. 67, 6084-6089.
52. Parameswaran, G. I., Sethi, S., Murphy, T. F. (2011) Effects of bacterial infection on airway antimicrobial peptides and proteins in COPD. Chest 140, 611-617.
53. Barlow, P. G., Svoboda, P., Mackellar, A., Nash, A. A., York, I. A., Pohl, J., Davidson, D. J., Donis, R. O. (2011) Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37. PLoS One 6, e25333.
54. Bergman, P., Walter-Jallow, L., Broliden, K., Agerberth, B., Soderlund, J. (2007) The antimicrobial peptide LL-37 inhibits HIV-1 replication. Curr. HIV Res. 5, 410-415.
55. Lai, Y., Adhikarakunnathu, S., Bhardwaj, K., Ranjith-Kumar, C. T., Wen, Y., Jordan, J. L., Wu, L. H., Dragnea, B., San Mateo, L., Kao, C. C. (2011) LL37 and cationic peptides enhance TLR3 signaling by viral double-stranded RNAs. PLoS One 6, e26632.
56. Lopez-Garcia, B., Lee, P. H., Yamasaki, K., Gallo, R. L. (2005) Anti-fungal activity of cathelicidins and their potential role in Candida albicans skin infection. J. Invest. Dermatol. 125, 108-115.
57. Ong, P. Y., Ohtake, T., Brandt, C., Strickland, I., Boguniewicz, M., Ganz, T., Gallo, R. L., Leung, D. Y. (2002) Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med. 347, 1151-1160.
58. Steinmann, J., Halldorsson, S., Agerberth, B., Gudmundsson, G. H. (2009) Phenylbutyrate induces antimicrobial peptide expression. Antimicrob. Agents Chemother. 53, 5127-5133.
59. Gudmundsson, G. H., Bergman, P., Andersson, J., Raqib, R., Agerberth, B. (2010) Battle and balance at mucosal surfaces-the story of Shigella and antimicrobial peptides. Biochem. Biophys. Res. Commun. 396, 116-119.
60. Sarker, P., Ahmed, S., Tiash, S., Rekha, R. S., Stromberg, R., Andersson, J., Bergman, P., Gudmundsson, G. H., Agerberth, B., Raqib, R. (2011) Phenylbutyrate counteracts Shigella mediated downregulation of cathelicidin in rabbit lung and intestinal epithelia: a potential therapeutic strategy. PLoS One 6, e20637.
61. Schauber, J., Oda, Y., Buchau, A. S., Yun, Q. C., Steinmeyer, A., Zugel, U., Bikle, D. D., Gallo, R. L. (2008) Histone acetylation in keratinocytes enables control of the expression of cathelicidin and CD14 by 1,25-dihydroxyvitamin D3. J. Invest. Dermatol. 128, 816-824.
62. Kida, Y., Shimizu, T., Kuwano, K. (2006) Sodium butyrate up-regulates cathelicidin gene expression via activator protein-1 and histone acetylation at the promoter region in a human lung epithelial cell line, EBC-1. Mol. Immunol. 43, 1972-1981.
63. Baeke, F., Takiishi, T., Korf, H., Gysemans, C., Mathieu, C. (2010) Vitamin D: modulator of the immune system. Curr. Opin. Pharmacol. 10, 482-496.
64. White, J. H. (2012) Vitamin D metabolism and signaling in the immune system. Rev Endocr Metab Disord. 13, 21-29.
65. Di Rosa, M., Malaguarnera, M., Nicoletti, F., Malaguarnera, L. (2011) Vitamin D3: a helpful immuno-modulator. Immunology 134, 123-139.
66. Adams, J. S., Gacad, M. A. (1985) Characterization of 1 α-hydroxylation of vitamin D3 sterols by cultured alveolar macrophages from patients with sarcoidosis. J. Exp. Med. 161, 755-765.
67. Gyetko, M. R., Hsu, C. H., Wilkinson, C. C., Patel, S., Young, E. (1993) Monocyte 1 α-hydroxylase regulation: induction by inflammatory cytokines and suppression by dexamethasone and uremia toxin. J. Leukoc. Biol. 54, 17-22.
68. Liu, P. T., Stenger, S., Li, H., Wenzel, L., Tan, B. H., Krutzik, S. R., Ochoa, M. T., Schauber, J., Wu, K., Meinken, C., Kamen, D. L., Wagvan ner, M., Bals, R., Steinmeyer, A., Zugel, U., Gallo, R. L., Eisenberg, D., Hewison, M., Hollis, B. W., Adams, J. S., Bloom, B. R., Modlin, R. L. (2006) Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311, 1770-1773.
69. Krutzik, S. R., Hewison, M., Liu, P. T., Robles, J. A., Stenger, S., Adams, J. S., Modlin, R. L. (2008) IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway. J. Immunol. 181, 7115-7120.
70. Provvedini, D. M., Tsoukas, C. D., Deftos, L. J., Manolagas, S. C. (1983) 1,25-Dihydroxyvitamin D3 receptors in human leukocytes. Science 221, 1181-1183.
71. Carlberg, C. (2003) Current understanding of the function of the nuclear vitamin D receptor in response to its natural and synthetic ligands. Recent Results Cancer Res. 164, 29-42.
72. Gombart, A. F., O'Kelly, J., Saito, T., Koeffler, H. P. (2007) Regulation of the CAMP gene by 1,25(OH)2D3 in various tissues. J. Steroid Biochem. Mol. Biol. 103, 552-557.
73. Gombart, A. F., Borregaard, N., Koeffler, H. P. (2005) Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J. 19, 1067-1077.
74. Liu, P. T., Schenk, M., Walker, V. P., Dempsey, P. W., Kanchanapoomi, M., Wheelwright, M., Vazirnia, A., Zhang, X., Steinmeyer, A., Zugel, U., Hollis, B. W., Cheng, G., Modlin, R. L. (2009) Convergence of IL-1β and VDR activation pathways in human TLR2/1-induced antimicrobial responses. PLoS One 4, e5810.
75. Yim, S., Dhawan, P., Ragunath, C., Christakos, S., Diamond, G. (2007) Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25-dihydroxyvitamin D(3). J. Cyst. Fibros. 6, 403-410.
76. White, J. H. (2010) Vitamin D as an inducer of cathelicidin antimicrobial peptide expression: past, present and future. J. Steroid Biochem. Mol. Biol. 121, 234-238.
77. Peng, L., He, Z., Chen, W., Holzman, I. R., Lin, J. (2007) Effects of butyrate on intestinal barrier function in a Caco-2 cell monolayer model of intestinal barrier. Pediatr. Res. 61, 37-41.
78. Lewis, K., Lutgendorff, F., Phan, V., Soderholm, J. D., Sherman, P. M., McKay, D. M. (2010) Enhanced translocation of bacteria across metabolically stressed epithelia is reduced by butyrate. Inflamm. Bowel Dis. 16, 1138-1148.
79. Gaudier, E., Rival, M., Buisine, M. P., Robineau, I., Hoebler, C. (2009) Butyrate enemas upregulate Muc genes expression but decrease adherent mucus thickness in mice colon. Physiol. Res. 58, 111-119.
80. Raqib, R., Sarker, P., Bergman, P., Ara, G., Lindh, M., Sack, D. A., Nasirul Islam, K. M., Gudmundsson, G. H., Andersson, J., Agerberth, B. (2006) Improved outcome in Shigellosis associated with butyrate induction of an endogenous peptide antibiotic. Proc. Natl. Acad. Sci. USA 103, 9178-9183.
81. Kong, J., Zhang, Z., Musch, M. W., Ning, G., Sun, J., Hart, J., Bissonnette, M., Li, Y. C. (2008) Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am. J. Physiol. Gastrointest. Liver Physiol. 294, G208-G216.
82. Cantorna, M. T., Munsick, C., Bemiss, C., Mahon, B. D. (2000) 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J. Nutr. 130, 2648-2652.
83. Ni, Y. F., Wang, J., Yan, X. L., Tian, F., Zhao, J. B., Wang, Y. J., Jiang, T. (2010) Histone deacetylase inhibitor, butyrate, attenuates lipopolysaccharide-induced acute lung injury in mice. Respir. Res. 11, 33.
84. Weber, G., Heilborn, J. D., Chamorro Jimenez, C. I., Hammarsjo, A., Torma, H., Stahle, M. (2005) Vitamin D induces the antimicrobial protein hCAP18 in human skin. J. Invest. Dermatol. 124, 1080-1082.
85. Heilborn, J. D., Weber, G., Gronberg, A., Dieterich, C., Stahle, M. (2010) Topical treatment with the vitamin D analogue calcipotriol enhances the upregulation of the antimicrobial protein hCAP18/LL-37 during wounding in human skin in vivo. Exp. Dermatol. 19, 332-338.
86. Vinolo, M. A., Hatanaka, E., Lambertucci, R. H., Newsholme, P., Curi, R. (2009) Effects of short chain fatty acids on effector mechanisms of neutrophils. Cell Biochem. Funct. 27, 48-55.
87. Takano, Y., Mitsuhashi, H., Ueno, K. (2011) 1α,25-Dihydroxyvitamin D inhibits neutrophil recruitment in hamster model of acute lung injury. Steroids 76, 1305-1309.
88. Hirsch, D., Archer, F. E., Joshi-Kale, M., Vetrano, A. M., Weinberger, B. (2011) Decreased anti-inflammatory responses to vitamin D in neonatal neutrophils. Mediators Inflamm. 2011, 598345.
89. Saemann, M. D., Bohmig, G. A., Osterreicher, C. H., Burtscher, H., Parolini, O., Diakos, C., Stockl, J., Horl, W. H., Zlabinger, G. J. (2000) Anti-inflammatory effects of sodium butyrate on human monocytes: potent inhibition of IL-12 and up-regulation of IL-10 production. FASEB J. 14, 2380-2382.
90. Segain, J. P., Raingeard de la Bletiere, D., Bourreille, A., Leray, V., Gervois, N., Rosales, C., Ferrier, L., Bonnet, C., Blottiere, H. M., Galmiche, J. P. (2000) Butyrate inhibits inflammatory responses through NFκB inhibition: implications for Crohn's disease. Gut 47, 397-403.
91. Liu, P. T., Stenger, S., Tang, D. H., Modlin, R. L. (2007) Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J. Immunol. 179, 2060-2063.
92. Gutierrez, M. G., Master, S. S., Singh, S. B., Taylor, G. A., Colombo, M. I., Deretic, V. (2004) Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 119, 753-766.
93. Yuk, J. M., Shin, D. M., Lee, H. M., Yang, C. S., Jin, H. S., Kim, K. K., Lee, Z. W., Lee, S. H., Kim, J. M., Jo, E. K. (2009) Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe 6, 231-243.
94. Millard, A. L., Mertes, P. M., Ittelet, D., Villard, F., Jeannesson, P., Bernard, J. (2002) Butyrate affects differentiation, maturation and function of human monocyte-derived dendritic cells and macrophages. Clin. Exp. Immunol. 130, 245-255.
95. Stempelj, M., Kedinger, M., Augenlicht, L., Klampfer, L. (2007) Essential role of the JAK/STAT1 signaling pathway in the expression of inducible nitric-oxide synthase in intestinal epithelial cells and its regulation by butyrate. J. Biol. Chem. 282, 9797-9804.
96. Wang, B., Morinobu, A., Horiuchi, M., Liu, J., Kumagai, S. (2008) Butyrate inhibits functional differentiation of human monocyte-derived dendritic cells. Cell. Immunol. 253, 54-58.
97. Penna, G., Adorini, L. (2000) 1 α,25-Dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol. 164, 2405-2411.
98. Sly, L. M., Lopez, M., Nauseef, W. M., Reiner, N. E. (2001) 1α,25-Dihydroxyvitamin D3-induced monocyte antimycobacterial activity is regulated by phosphatidylinositol 3-kinase and mediated by the NADPHdependent phagocyte oxidase. J. Biol. Chem. 276, 35482-35493.
99. Dombrowski, Y., Peric, M., Koglin, S., Ruzicka, T., Schauber, J. (2010) Control of cutaneous antimicrobial peptides by vitamin D3. Arch. Dermatol. Res. 302, 401-408.
100. Gilliet, M., Lande, R. (2008) Antimicrobial peptides and self-DNA in autoimmune skin inflammation. Curr. Opin. Immunol. 20, 401-407.
101. Sun, C. L., Zhang, F. Z., Li, P., Bi, L. Q. (2011) LL-37 expression in the skin in systemic lupus erythematosus. Lupus 20, 904-911.
102. Chen, C. I., Schaller-Bals, S., Paul, K. P., Wahn, U., Bals, R. (2004) β-defensins and LL-37 in bronchoalveolar lavage fluid of patients with cystic fibrosis. J. Cyst. Fibros. 3, 45-50.
103. Wu, W. K., Wang, G., Coffelt, S. B., Betancourt, A. M., Lee, C. W., Fan, D., Wu, K., Yu, J., Sung, J. J., Cho, C. H. (2010) Emerging roles of the host defense peptide LL-37 in human cancer and its potential therapeutic applications. Int. J. Cancer 127, 1741-1747.
104. Li, Y. (2009) The role of antimicrobial peptides in cardiovascular physiology and disease. Biochem. Biophys. Res. Commun. 390, 363-367.